Cargando…

Alzheimer’s disease treatment: The share of herbal medicines

One of the most frequent forms of dementia in neurological disorders is Alzheimer’s disease (AD). It is a chronic neurodegenerative disease characterized by impaired learning and memory. Pathological symptoms as extracellular amyloid-beta (Aβ) plaques and intracellular accumulation of neurofibrillar...

Descripción completa

Detalles Bibliográficos
Autores principales: Soheili, Masoud, Karimian, Mohammad, Hamidi, Gholamali, Salami, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061323/
https://www.ncbi.nlm.nih.gov/pubmed/33953850
http://dx.doi.org/10.22038/IJBMS.2020.50536.11512
_version_ 1783681542695944192
author Soheili, Masoud
Karimian, Mohammad
Hamidi, Gholamali
Salami, Mahmoud
author_facet Soheili, Masoud
Karimian, Mohammad
Hamidi, Gholamali
Salami, Mahmoud
author_sort Soheili, Masoud
collection PubMed
description One of the most frequent forms of dementia in neurological disorders is Alzheimer’s disease (AD). It is a chronic neurodegenerative disease characterized by impaired learning and memory. Pathological symptoms as extracellular amyloid-beta (Aβ) plaques and intracellular accumulation of neurofibrillary tangles occur in AD. Due to the aging of the population and increased prevalence of AD, discovery of new therapeutic agents with the highest effectiveness and fewer side effect seems to be necessary. Numerous synthetic medicines such as tacrine, donepezil, galantamine, rivastigmine, memantine, glutathione, ascorbic acid, ubiquinone, ibuprofen, and ladostigil are routinely used for reduction of the symptoms and prevention of disease progression. Nowadays, herbal medicines have attracted popular attention for numerous beneficial effects with little side effects. Lavandula angustifolia, Ginkgo biloba, Melissa officinalis, Crocus sativus, Ginseng, Salvia miltiorrhiza, and Magnolia officinalis have been widely used for relief of symptoms of some neurological disorders. This paper reviews the therapeutic effects of phytomedicines with prominent effects against various factors implicated in the emergence and progression of AD.
format Online
Article
Text
id pubmed-8061323
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-80613232021-05-04 Alzheimer’s disease treatment: The share of herbal medicines Soheili, Masoud Karimian, Mohammad Hamidi, Gholamali Salami, Mahmoud Iran J Basic Med Sci Review Article One of the most frequent forms of dementia in neurological disorders is Alzheimer’s disease (AD). It is a chronic neurodegenerative disease characterized by impaired learning and memory. Pathological symptoms as extracellular amyloid-beta (Aβ) plaques and intracellular accumulation of neurofibrillary tangles occur in AD. Due to the aging of the population and increased prevalence of AD, discovery of new therapeutic agents with the highest effectiveness and fewer side effect seems to be necessary. Numerous synthetic medicines such as tacrine, donepezil, galantamine, rivastigmine, memantine, glutathione, ascorbic acid, ubiquinone, ibuprofen, and ladostigil are routinely used for reduction of the symptoms and prevention of disease progression. Nowadays, herbal medicines have attracted popular attention for numerous beneficial effects with little side effects. Lavandula angustifolia, Ginkgo biloba, Melissa officinalis, Crocus sativus, Ginseng, Salvia miltiorrhiza, and Magnolia officinalis have been widely used for relief of symptoms of some neurological disorders. This paper reviews the therapeutic effects of phytomedicines with prominent effects against various factors implicated in the emergence and progression of AD. Mashhad University of Medical Sciences 2021-02 /pmc/articles/PMC8061323/ /pubmed/33953850 http://dx.doi.org/10.22038/IJBMS.2020.50536.11512 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Soheili, Masoud
Karimian, Mohammad
Hamidi, Gholamali
Salami, Mahmoud
Alzheimer’s disease treatment: The share of herbal medicines
title Alzheimer’s disease treatment: The share of herbal medicines
title_full Alzheimer’s disease treatment: The share of herbal medicines
title_fullStr Alzheimer’s disease treatment: The share of herbal medicines
title_full_unstemmed Alzheimer’s disease treatment: The share of herbal medicines
title_short Alzheimer’s disease treatment: The share of herbal medicines
title_sort alzheimer’s disease treatment: the share of herbal medicines
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061323/
https://www.ncbi.nlm.nih.gov/pubmed/33953850
http://dx.doi.org/10.22038/IJBMS.2020.50536.11512
work_keys_str_mv AT soheilimasoud alzheimersdiseasetreatmenttheshareofherbalmedicines
AT karimianmohammad alzheimersdiseasetreatmenttheshareofherbalmedicines
AT hamidigholamali alzheimersdiseasetreatmenttheshareofherbalmedicines
AT salamimahmoud alzheimersdiseasetreatmenttheshareofherbalmedicines